Resyl

/ GSK

Adults: 5 to 10 mL 4 times per day.
Resyl Syrup contains 6% alcohol by volume (corresponding to 5% weight/vol.). Resyl Syrup is not suitable for children or adolescents.
Use the graduated measuring cup included in the package. Wash and dry the graduated measuring cup after each use and between each user.
In addition to treatment, drinking plenty of liquid is recommended (e.g. infusions, fruit juices).

Expectorant, relieves cough.

Hypersensitivity to the active substance or to one of the excipients in the composition.
Intolerance to fructose, for example, in case of hereditary fructose-1.6-diphosphatase intolerance (fructose is the result of the degradation of the sweetener sorbitol).

Caution should be used in case of gastrointestinal disorders, myasthenia gravis, or with limited kidney function.
In case of bronchospasms or hypersensitivity reactions, treatment should be discontinued immediately, and the doctor informed.
In the following cases, patients must also contact their doctor:
– respiratory failure,
– cough with bloody expectorate or production of excessive bronchial mucus,
– persistent or chronic cough, e.g., in smokers, asthmatics, in case of chronic bronchitis or emphysema,
– if the cough lasts more than 7 days, relapses, or is accompanied by fever, a skin rash, or persistent headaches.
Resyl Syrup contains 5% weight/volume of alcohol. Adults take up to 470 mg of alcohol (10 mL) per dose.
A risk for health exists, among others, for individuals with liver disease, alcoholics, epileptics, individuals with brain damage, pregnant or breast-feeding women, and children. The effect of other medicinal products can be strengthened or disturbed.
The concomitant administration of an antitussive is not medically indicated. It can cause undesirable swelling of the secretions with a risk of bronchospasm and an infection of the respiratory tract due to the inhibition of the cough reflex and the physiological self-cleaning of the respiratory tracts.

See prescribing information for full details.

Resyl Syrup can emphasize the effect of sedatives and myorelaxants.

No evidence suggests a risk during pregnancy. However, controlled studies in animals or pregnant women are not available. Under these conditions, Resyl Syrup will be administered only in case of absolute necessity.
It is not known whether guaifenesin is excreted in breast milk. For safety reasons, women who are breastfeeding must not take Resyl Syrup.

Taking a greater quantity than the recommended posology may cause serious health problems. In case of overdose, medical help should be sought immediately, even if there is no symptom.
Gastrointestinal disorders, nausea, and vomiting were reported after taking guaifenesin, in particular after high doses. Somnolence can also occur.
The creation of kidney stones was also observed after taking high doses of guaifenesin. Guaifenesin once absorbed is however quickly metabolised and excreted through the urine. Treatment is symptomatic.